Latest News in the pharma Industry

Top Stories

UCB Pharma with Oxford University to Develop Drugs for Serious Diseases

UCB Pharma with Oxford University to Develop Drugs for Serious Diseases

22 Mar 2012

UCB will fund the collaboration with ?3.6 million over three years to develop medicines that will treat serious diseases in immunology and neurology.

Read more 
Abbott Announces Name for New Drug Company

Abbott Announces Name for New Drug Company

22 Mar 2012

The name for its new research-based pharmaceutical company is derived from a combination of Abbott and 'vie,' which references the Latin root 'vi' meaning life.

Read more 
Astellas Withdraws Application for Extension of Qutenza Indication

Astellas Withdraws Application for Extension of Qutenza Indication

21 Mar 2012

The company stated that it decided to withdraw the application based on the CHMP's view that the data provided do not allow the Committee to conclude on a positive benefit-risk balance.

Read more 
Eisai Expands Business in EMEA Region

Eisai Expands Business in EMEA Region

21 Mar 2012

The new expansion in the European, Middle Eastern and African markets is part of the company's plan to have a presence in the top 20 pharmaceutical market regions by 2015.

Read more 
Shire Licenses CNS Drug

Shire Licenses CNS Drug

21 Mar 2012

Heptares will receive an upfront option grant and exercise payments and is eligible to receive future development and commercial milestone payments of as much as $190 million, plus royalties on sales.

Read more 
SanBio Starts Enrollment in Clinical Trial of Stem Cell Therapy for Chronic Stroke

SanBio Starts Enrollment in Clinical Trial of Stem Cell Therapy for Chronic Stroke

21 Mar 2012

The stem cell therapy SB623 is derived from adult bone marrow and has shown safety and efficacy in rodent models of chronic stroke.

Read more 
Health Canada Facilitates Review Process to Ease Drug Shortage

Health Canada Facilitates Review Process to Ease Drug Shortage

21 Mar 2012

It usually takes around six months to complete an assessment and approve a drug for use in Canada. However, Health Canada is speeding up its drug review process to ease the drug shortage.

Read more 
Sigma-Aldrich Opens New Facility in China

Sigma-Aldrich Opens New Facility in China

19 Mar 2012

The new facility will provide localized packaging, analytical services and quality control for high-quality products to support the Company's research and industrial customers in the region.

Read more 
Sanofi to Close Manufacturing Plant in Newcastle

Sanofi to Close Manufacturing Plant in Newcastle

19 Mar 2012

The move comes as the company is forced to contend with European health spending cuts and generic competition to Plavix, the top-selling blood thinner, which is manufactured at the site.

Read more 
Bayer Sets Ambitious Targets for 2014

Bayer Sets Ambitious Targets for 2014

15 Mar 2012

Sales of Bayer HealthCare are expected to reach approximately EUR 20 billion in 2014, while Bayer CropScience aims to raise sales to more than EUR 8 billion.

Read more 
CPhI Worldwide to Return to Frankfurt in 2013

CPhI Worldwide to Return to Frankfurt in 2013

15 Mar 2012

UBM has announced that CPhI Worldwide, ICSE, P-MEC Europe and InnoPack will return to Frankfurt, Germany from 22nd to 24th October 2013. The events will run this year from 9th to 11th October in Madrid and had a record breaking year at the Messe Frankf...

Read more 
Biocon & Pfizer End Biosimilar Partnership

Biocon & Pfizer End Biosimilar Partnership

14 Mar 2012

Biocon and Pfizer have ended their biosimilar insulin alliance. All rights licensed to Pfizer will now be transferred back to Biocon.

Read more